A 23-year-old male patient who presented with impaired kidney function tests attended to hospital for hemodialysis and underwent 18 F-FDG positron emission tomography/computed tomography (PET/CT) examination for the metabolic characterization of the intra-abdominal mass which was found in the ultrasonography. 18 F-FDG PET/CT revealed a mass lesion adjacent to the liver which was hypermetabolic and the pathology of the lesion was determined as amyloidosis. To the best of our knowledge, the case with 18 F-FDG PET/CT images of a huge amyloid mass is the first in the literature.
Abdominal lymph node biopsy and wedge resection from the liver parenchyma and adjecent lymph node were performed. The pathological result of the mass was found to be an amyloid deposition. Additionally, amyloid deposits were also found in the hepatocytes. A) Acellular, amorphous, eosinophilic amyloid deposits in hepatocyte cytoplasm (hematoxylin and eosin, x200), B) amyloid was stained brown to orange with Kongo Red dye in the hepatocyte cytoplasm (Kongo Red, x200), C) amyloid deposits in the lymph node parenchyma (Kongo Red, x200). In microscopic examination, acellular, amorphous, eosinophilic deposits were detected in the lymph node parenchyma and also in the hepatocyte cytoplasm and disse space in the liver parenchyma. Additionally depositions were shown in the vascular walls indicating systemic amyloidosis. The deposits were stained brown to orange with Kongo Red dye and also showed birefringence under polarized light, which was compatible with amyloidosis. To specify the type of amyloid proteins immunohistochemically, AA amyloid dye was applied to the biopsy materials and positive staining was observed. Primary amyloidosis presented with hepatic involvement is a rare disease that was previously reported in some cases with multiple myeloma (1) . Additionally, there are case reports about 18 F-FDG accumulation of primary amyloidosis in the lungs (2) . A previous case report showed diffuse increased liver 18 F-FDG uptake (3), however the series comparing systemic and localized amyloidosis indicate that systemic amyloidosis may not accumulate 18 F-FDG but localized amyloidosis does (4) . The lesion in this report was located in close proximity to the liver, spleen and stomach but not in the any of these organs. The probable reason for the kidney impairment was amiloidosis as well. The prediagnosis of multiple myeloma or plasmocytoma was excluded by laboratory analysis. Kidney biopsy was not performed however amyloid deposition in the normal liver parenchyma was shown by pathology results demonstrating systemic amlioidosis. However the reason of this amiloidosis could not be determined. The patient also has some 18 F-FDG uptake in gastric region which was explained by gastritis. In the literature, this is the first case report with systemic and localized amyloidosis presented with kidney failure and gross abdominal mass showing high 18 F-FDG uptake.
